Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/735
Title: | Infusion-fill method versus standard auto-fill trial of void protocol following a TVT-exact procedure: A randomised controlled trial | Authors: | Mowat, A. Pelecanos, A. Brown, B. Frazer, M. Mowat, V. |
Issue Date: | 2018 | Source: | The Australian & New Zealand journal of obstetrics & gynaecology Jan 31 , 2018 | Journal Title: | The Australian & New Zealand journal of obstetrics & gynaecology | Journal: | Aust N Z J Obstet Gynaecol | Abstract: | OBJECTIVE: To establish whether the infusion method trial of void (TOV) after a mid-urethral sling procedure, in contrast to the standard auto-fill TOV, permits discharge home from recovery, as these procedures are eminently suited to same day discharge, and the delay in achieving a successful TOV often keeps the patient in hospital overnight. METHOD: A randomised controlled trial performed between December 2014 and April 2016 at the University Hospital, enrolling 40 women undergoing a mid-urethral sling procedure for stress urinary incontinence. The women were randomised to infusion method or auto-fill method TOV. The primary outcome was discharge home from the recovery area of theatre. RESULTS: Discharge from recovery was not different between the two groups (odds ratio (OR) 1.3 95% CI: 0.3-5.9, P = 0.71). The rate of TOV being successfully passed in recovery was higher in the infusion-fill group compared to the standard auto-fill group (OR 4.5 95% CI 1.2-17.4, P = 0.025). This means that three women will undergo the infusion-fill to achieve one more successful TOV in recovery. CONCLUSIONS: The infusion method resulted in more women passing their TOV in recovery but this did not translate into more discharges from recovery.1479-828xMowat, Alexandra | DOI: | 10.1111/ajo.12780 | Keywords: | mid-urethral slingtrial of void | Type: | Article |
Appears in Sites: | Gold Coast Health Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.